The main goal was to evaluate the efficacy with the vaccine as opposed to placebo in lessening cocaine use. Secondary objectives included confirming vaccine immunogenicity as a result of IgG anti-cocaine antibody stages and assessing the security and tolerability of vaccination through a 20 week review and at 24 week https://kabire318xvs6.wikififfi.com/user